Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT)

Grants and Contracts Details

StatusFinished
Effective start/end date4/17/1712/18/18

Funding

  • Baxter Healthcare Co: $110,501.00